Floatz logo

Therapeutic Asset Ratings

137 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Cyclophosphamide
Breast Neoplasms
Merck Sharp & Dohme LLCP4BB (70)
Docetaxel
Breast Neoplasms
Universitas AirlanggaP4BB (70)
EXEMESTANE
Breast Neoplasms
Fujian Cancer HospitalP4BB (70)
Inno-206
Breast Neoplasms
Merck Sharp & Dohme LLCP4BB (70)
Letrozole
Breast Neoplasms
Fujian Cancer HospitalP4BB (70)
TAMOXIFEN
Breast Neoplasms
Eli Lilly and CompanyP3BB (70)
Epirubicin
Breast Neoplasms
Universitas AirlanggaP4BB (69)
ERIBULIN MONOMETHANESULFONATE
Breast Neoplasms
Fudan UniversityP4BB (69)
Palbociclib
Breast Neoplasms
Eli Lilly and CompanyP4BB (69)
Arimidex
Breast Neoplasms
Fujian Cancer HospitalP4BB (68)
Capecitabine
Breast Neoplasms
Kristina A. FanucciP4BB (68)
TRASTUZUMAB
Breast Neoplasms
Merck Sharp & Dohme LLCP3BB (68)
FLUOROURACILUM
Breast Neoplasms
Rutgers, The State University of New JerseyP4BB (67)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Breast Neoplasms
Merck Sharp & Dohme LLCP4BB (67)
ROPIVACAINE
Breast Neoplasms
Fudan UniversityP4BB (67)
FULVESTRANT
Breast Neoplasms
Eli Lilly and CompanyP4BB (66)
Carboplatin
Breast Neoplasms
BioNTech SEP3BB (66)
Eloxatin
Breast Neoplasms
Kristina A. FanucciP3BB (66)
Abemaciclib
Breast Neoplasms
Eli Lilly and CompanyP4BB (64)
Zoladex
Breast Neoplasms
Eli Lilly and CompanyP4BB (64)
Eribulin
Breast Neoplasms
BioNTech SEP4B (63)
LEUPROLIDE
Breast Neoplasms
Eli Lilly and CompanyP4B (63)
Ribociclib
Breast Neoplasms
Eli Lilly and CompanyP4B (63)
Olaparib
Breast Neoplasms
Merck Sharp & Dohme LLCP3B (62)
Vinorelbine
Breast Neoplasms
Sun Yat-sen UniversityP3B (62)
Showing 1 to 25 of 137 assets
PreviousPage 1 of 6Next